| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e81afd7465ffba8139e557bd8c35b5eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79cb019ca9ea71815975baa3732b0df5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-304 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-97 |
| filingDate |
2016-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8c776077803ca14279a41d6ea29ac89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e533ba193dd36f23b842211128196916
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79c24bd4516974965adda4c816b7d1d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_866eaeb726dde0bf2e0a17bb425b21bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b6667146a8b1260f0b5394142ba7843
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92b5163d16af9ddcd583b05aed23d1db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4aef0a44b11ff2a79d430b61336c09ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8cb90fe3d8c11e9e99dab0d88ba7644 |
| publicationDate |
2017-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101787266-B1 |
| titleOfInvention |
Composition for Anti-Allergy Using an Extract of Dipterocarpus intricatus |
| abstract |
The present invention relates to the use of Dipterocarpus intricactus extract showing inhibitory activity on the degranulation and cytokine production inhibitory activity when treated with an IgE and antigen (DNP-BSA) -activated mast cell line RBL-2H3 (rat basophilic leukemia) A composition for anti-allergy is disclosed. |
| priorityDate |
2016-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |